Article: Other News To Note.

Aastrom Bioscience Inc., of Ann Arbor, Mich., received a Small Business Innovation Research Phase II grant from the National Institutes of Health in Bethesda, Md. The two-year award from the National Institute of Diabetes and Digestive and Kidney Diseases, also in Bethesda, totals $740,000, of which $324,000 has been received for the first year of the study.

Able Laboratories Inc., of Cranbury, N.J., plans to liquidate the company after efforts to bring its generic products back to the market have failed. In May, the company voluntarily recalled its products, suspending all manufacturing and distribution, because of concerns about the integrity of data used to ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!